Methyl 2-(3-chloro-4-fluorophenyl)acetate, 97%, 1g

2-(3-((2-BROMOPHENOXY)METHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 250mg

1,3-Bis(2,6-diisopropylphenyl)-1,3,2-diazaphospholidine 2-Oxide, 97%, 1g

Vortioxetine hydrobromide, 97.0%, 25g

Cyclopropyl isocyanate, 95.0%, 5g

2-azaspiro[3.3]heptan-6-one; 2,2,2-trifluoroacetic acid, 95.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((diphenyl(p-tolyl)methyl)amino)pentanoic acid, 97%, 1g

2-Amino-6-methoxypyridine>98.0%(GC)(T)1g

7-Bromo-6-fluoro-3,4-dihydroquinoxalin-2(1H)-one, 95%, 100mg

1-Phenylazetidin-3-ol, 95.0%, 1g

4-Fluoro-1H-indol-5-ol, 95.0%, 250mg

2-Octenylsuccinic Anhydride (cis- and trans- mixture)>95.0%(GC)(T)500g

Tert-butyl (2-hydroxy-2-(4-nitrophenyl)ethyl)carbamate, 98%, 500mg